Should You Buy CVS Health Stock While It's Under $100?

CVS Health, a prominent pharmaceutical retailer and health insurance provider, is currently trading at a low price point below $100. This pharmaceutical giant boasts a diversified healthcare portfolio that can offer investors ample exposure to the sector. Earlier this year, the company's stock reached a high of more than $110; however, it has been experiencing a significant decline in recent times.

Investors are now wondering if this leading healthcare stock could present an excellent opportunity to buy while it trades well below the $100 mark.

In August, CVS Health reported impressive earnings, with revenue up by more than 7% to $106.1 billion. The company further boosted its earnings per share (EPS) forecast for the year, projecting diluted EPS to range between $6.84 and $7.04, a substantial improvement from previous years. For instance, in 2025, diluted EPS was only $1.39, and in the previous year, it was $3.66, both affected by restructuring and goodwill impairment charges.

Given the recent improvement in financial statements and heightened growth prospects, CVS Health seems well-positioned to deliver even stronger financials this year. The company's latest earnings are expected to be released next week on November 4. Consequently, shares of CVS Health have surged around 17% this year, outperforming the S&P 500, which has risen by a modest 12% thus far in 2026.

Despite the recent drop in stock price, CVS Health remains reasonably priced, trading at a forward price-to-earnings multiple of 11, significantly lower than the S&P 500's average of 19. This valuation suggests that the stock could potentially rise to over $100 in the near future or even surpass that level, given its improved results and modest valuation. Additionally, CVS Health yields a solid 2.9% dividend, making it an attractive option for investors seeking an above-average income stock with minimal volatility.

For investors looking to diversify their portfolios with a top healthcare stock or seek an exceptional dividend-paying stock that is unlikely to cause concern, CVS Health could be an excellent choice. The company's strong financial performance, promising growth, and affordable valuation make it a highly attractive investment opportunity at the moment.